{"title":"Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: an ultrastructural study.","authors":"Yuko Ehara, Nanako Yamada, Takashi Horie, Ryota Furuichi, Yuichi Yoshida, Osamu Yamamoto","doi":"10.1093/mmy/myaf016","DOIUrl":null,"url":null,"abstract":"<p><p>Lesional nails of 10 patients with onychomycosis (tinea unguium) were investigated by transmission electron microscopy (TEM) to gain an insight into in vivo morphological changes of dermatophytes after application of a clinical dosage of topical luliconazole (LLCZ) 5% nail solution. In these cases, Trichophyton rubrum was identified in 3 cases and Trichophyton interdigitale was identified in 4 cases (3 unidentified cases; we were unable to identify either the genus or species). Specimens from tinea unguium before and after topical LLCZ application (maximum of 14 days) were observed by TEM. Two types of morphological changes of hyphae were revealed. Intracytoplasmic degeneration without antecedent obvious changes in the cell wall (type 1 degeneration) and degeneration of the fungal cell wall preceding intracytoplasmic changes (type 2 degeneration) were observed. We also examined in vivo morphological changes of dermatophytes in tinea pedis treated with ketoconazole (KCZ) to compare the morphological changes in the cell wall, plasma membrane and cytoplasm to those after application of LLCZ. Intracytoplasmic degeneration (type 1 degeneration) was observed in tinea pedis scales treated with topical KCZ. We confirmed that topical LLCZ 5% nail solution had acting points on the plasma membrane, cell wall and cytoplasm of dermatophyte hyphae and that various degrees of morphological changes in lesional nails of tinea unguium occurred during treatment with topical LLCZ 5% nail solution.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myaf016","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Lesional nails of 10 patients with onychomycosis (tinea unguium) were investigated by transmission electron microscopy (TEM) to gain an insight into in vivo morphological changes of dermatophytes after application of a clinical dosage of topical luliconazole (LLCZ) 5% nail solution. In these cases, Trichophyton rubrum was identified in 3 cases and Trichophyton interdigitale was identified in 4 cases (3 unidentified cases; we were unable to identify either the genus or species). Specimens from tinea unguium before and after topical LLCZ application (maximum of 14 days) were observed by TEM. Two types of morphological changes of hyphae were revealed. Intracytoplasmic degeneration without antecedent obvious changes in the cell wall (type 1 degeneration) and degeneration of the fungal cell wall preceding intracytoplasmic changes (type 2 degeneration) were observed. We also examined in vivo morphological changes of dermatophytes in tinea pedis treated with ketoconazole (KCZ) to compare the morphological changes in the cell wall, plasma membrane and cytoplasm to those after application of LLCZ. Intracytoplasmic degeneration (type 1 degeneration) was observed in tinea pedis scales treated with topical KCZ. We confirmed that topical LLCZ 5% nail solution had acting points on the plasma membrane, cell wall and cytoplasm of dermatophyte hyphae and that various degrees of morphological changes in lesional nails of tinea unguium occurred during treatment with topical LLCZ 5% nail solution.
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.